A 28-year-old man from Delhi presents with a 10-day history of sustained fever (39.5°C), headache, myalgia, and rose spots on the trunk. Blood culture is positive for Salmonella typhi. He is currently on ceftriaxone 2 g IV 12-hourly. On day 3 of therapy, his fever persists, and he develops altered mental status with neck stiffness. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient has enteric fever with clinical signs of meningitis (altered mental status, neck stiffness) developing during appropriate antibiotic therapy. The key issue is **CNS involvement in typhoid**, which requires both diagnostic confirmation and therapeutic optimization. ## Pathophysiology of Typhoid Meningitis **Key Point:** Salmonella typhi can cause meningitis in 5–10% of severe enteric fever cases, particularly in the second week of illness. CNS penetration of antibiotics is critical. ## Management Algorithm ```mermaid flowchart TD A[Enteric fever + signs of meningitis]:::outcome --> B{CSF findings confirm meningitis?}:::decision B -->|Presumed meningitis| C[Lumbar puncture immediately]:::action C --> D[Start dexamethasone 10 mg IV 6-hourly]:::action D --> E[Continue/optimize ceftriaxone 2g IV 8-hourly]:::action E --> F[Adequate CSF penetration achieved]:::outcome B -->|No meningitis| G[Continue current therapy]:::action ``` ## Why Ceftriaxone Remains First-Line | Feature | Ceftriaxone | Chloramphenicol | Fluoroquinolone | |---------|-------------|-----------------|----------------| | **CSF penetration** | Excellent (meningitis doses) | Good | Poor | | **Efficacy in typhoid meningitis** | First-line | Historical; less used now | Not recommended | | **Current resistance patterns** | Covers most S. typhi | Resistance increasing | High resistance in India | | **Dexamethasone synergy** | Yes (improves outcomes) | Limited data | No | **High-Yield:** Ceftriaxone 2 g IV **8-hourly** (not 12-hourly) is the meningitis-dose regimen for typhoid CNS involvement. ## Role of Dexamethasone **Clinical Pearl:** Adjunctive dexamethasone (10 mg IV 6-hourly × 4 days) reduces mortality and neurological sequelae in bacterial meningitis, including typhoid meningitis. It should be given **before or with the first antibiotic dose** once meningitis is suspected. ## Lumbar Puncture Findings in Typhoid Meningitis - **Cell count:** 100–500 cells/μL (lymphocytic predominance) - **Protein:** Elevated (50–200 mg/dL) - **Glucose:** Normal or mildly reduced (CSF:blood ratio >0.4) - **Gram stain/culture:** Often negative; culture positive in ~50% of cases - **PCR:** Increasingly used for rapid diagnosis **Warning:** Do not delay lumbar puncture if meningitis is suspected clinically; it is both diagnostic and therapeutic (CSF pressure relief). ## Why Other Options Are Suboptimal **Option 1 (Correct):** Combines diagnostic confirmation (LP) with therapeutic optimization (dexamethasone + continued ceftriaxone at meningitis doses). **Option 2 (Chloramphenicol):** Historically used but now second-line due to increasing resistance in India and inferior outcomes compared to modern cephalosporins. Dexamethasone data are stronger with cephalosporins. **Option 3 (Dose increase alone):** Increasing ceftriaxone without dexamethasone is suboptimal; adjunctive steroid significantly improves CNS outcomes in meningitis. **Option 4 (Fluoroquinolone switch):** Fluoroquinolones have poor CSF penetration and are not recommended for meningitis. High resistance rates in India also make this inappropriate. **Key Point:** The combination of **LP (diagnostic) + dexamethasone (adjunctive) + optimized ceftriaxone (therapeutic)** is the gold standard for suspected typhoid meningitis.